Global, Regional, and National Epidemiology of Opioid Use Disorder Among Adolescents and Young Adults, 1990-2019

被引:0
作者
Han, Fulei [1 ,2 ]
Liu, Bixuan [1 ]
Wang, Ligang [3 ]
Zhu, Shuai [1 ]
Li, Xiaohui [1 ,4 ]
Kang, Shan [5 ]
Niu, Xiao [1 ,6 ,7 ]
Song, Jinlian [5 ]
Wu, Yili [1 ]
机构
[1] Qingdao Univ, Publ Hlth Coll, Dept Epidemiol & Hlth Stat, 308 Ningxia Rd, Qingdao 266071, Shandong, Peoples R China
[2] Qingdao Maternal & Child Hlth & Family Planning Se, Dept Birth Defects Prevent & Informat Management, Qingdao, Peoples R China
[3] Qingdao Mental Hlth Ctr, Gen Execut Off, Qingdao, Peoples R China
[4] Shandong Daizhuang Hosp, Dept Publ Hlth, Jining, Peoples R China
[5] Qingdao Univ, Qingdao Womens & Childrens Hosp, Dept Lab Med, Qingdao, Peoples R China
[6] Shandong First Med Univ, Shandong Canc Hosp & Inst, Jinan, Peoples R China
[7] Shandong Acad Med Sci, Jinan, Peoples R China
关键词
Opioid use disorder; Adolescents and young adults; Global burden of disease; Epidemiology; AGED; 10-24; YEARS; SEX-DIFFERENCES; BURDEN; PRESCRIPTION; DISEASE; PAIN;
D O I
10.1016/j.jadohealth.2024.12.015
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Purpose: Opioid use disorder (OUD) is a growing public health crisis. However, no study to date has systematically evaluated the burden of OUD among adolescents and young adults (AYAs). We aimed to report the global level and trends of OUD burden among AYAs. Methods: Data were obtained from the Global Burden of Disease study 2019, which was conducted from 1990 to 2019 in 204 countries. AYAs were defined as individuals aged 15-39 years, and the study period was 1990-2019. The burden of OUD was evaluated in terms of case numbers and age-standardized rates per 100,000 population. Results: In 2019, there were 2,396,734 incident cases, 14,502,031 prevalent cases, 43,447 deaths, and 8,651,931 disability-adjusted life years of OUD among AYAs globally. High-income North America had the greatest regional burden, with the United States having the highest burden nationally. From 1990 to 2019, age-standardized incidence rate (ASIR), age-standardized prevalence rate, age-standardized mortality rate, and age-standardized disability-adjusted life years rate (ASDR) showed upward trends, with average annual percentage change of 0.62, 0.81, 1.55, and 1.01, respectively. Despite the burden of OUD was higher in males than in females, the increment in ASIR was greater in females than in males after 2014. Nationally, OUD burden showed increasing trends in ASIR, age-standardized prevalence rate, and ASDR across 150 & thorn; countries, with the United States experiencing the greatest increase in age-standardized mortality rate and ASDR. Meanwhile, there was a positive correlation between sociodemographic index and OUD burden, with higher sociodemographic index associated with a higher burden of OUD in 2019. Discussion: OUD in AYAs is a major global public health issue, and the burden of OUD is increasing. This alarming trend underscores the urgent need for comprehensive prevention strategies, targeted interventions, and effective treatment options tailored to younger populations. (c) 2025 Society for Adolescent Health and Medicine. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:905 / 913
页数:9
相关论文
共 58 条
  • [1] Burden of non-communicable diseases among adolescents aged 10-24 years in the EU, 1990-2019: a systematic analysis of the Global Burden of Diseases Study 2019
    Armocida, Benedetta
    Monasta, Lorenzo
    Sawyer, Susan
    Bustreo, Flavia
    Segafredo, Giulia
    Castelpietra, Giulio
    Ronfani, Luca
    Pasovic, Maja
    Hay, Simon
    Perel, Pablo
    Beran, David
    [J]. LANCET CHILD & ADOLESCENT HEALTH, 2022, 6 (06) : 367 - 383
  • [2] Examining factors that shape use and access to diverted prescription opioids during an overdose crisis: A qualitative study in Vancouver, Canada
    Bardwell, Geoff
    Ivsins, Andrew
    Socias, M. Eugenia
    Kerr, Thomas
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 130
  • [3] Outpatient Opioid Prescriptions are Associated With Future Substance Use Disorders and Overdose Following Adolescent Trauma
    Bell, Teresa M.
    Raymond, Jodi L.
    Mongalo, Alejandro C.
    Adams, Zachary W.
    Rouse, Thomas M.
    Hatcher, LeRanna
    Russell, Katie
    Carroll, Aaron E.
    [J]. ANNALS OF SURGERY, 2022, 276 (06) : E955 - E960
  • [4] Opioid use disorder: is history repeating itself with sufentanil?
    Carswell, J. Wilson
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2023, 382
  • [5] Castaldelli-Maia JM, 2023, LANCET PSYCHIAT, V10, P85, DOI 10.1016/S2215-0366(22)00339-X
  • [6] Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2023, Understanding the opioid overdose epidemic
  • [7] The opioid epidemic
    Cook, Jocelynn L.
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2022, 85 : 53 - 58
  • [8] Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
    Cousin, Ewerton
    Duncan, Bruce B.
    Stein, Caroline
    Ong, Kanyin Liane
    Vos, Theo
    Abbafati, Cristiana
    Abbasi-Kangevari, Mohsen
    Abdelmasseh, Michael
    Abdoli, Amir
    Abd-Rabu, Rami
    Abolhassani, Hassan
    Abu-Gharbieh, Eman
    Accrombessi, Manfred Mario Kokou
    Adnani, Qorinah Estiningtyas Sakilah
    Afzal, Muhammad Sohail
    Agarwal, Gina
    Agrawaal, Krishna K.
    Agudelo-Botero, Marcela
    Ahinkorah, Bright Opoku
    Ahmad, Sajjad
    Ahmad, Tauseef
    Ahmadi, Keivan
    Ahmadi, Sepideh
    Ahmadi, Ali
    Ahmed, Ali
    Salih, Yusra Ahmed
    Akande-Sholabi, Wuraola
    Akram, Tayyaba
    Al Hamad, Hanadi
    Al-Aly, Ziyad
    Alcalde-Rabanal, Jacqueline Elizabeth
    Alipour, Vahid
    Aljunid, Syed Mohamed
    Al-Raddadi, Rajaa M.
    Alvis-Guzman, Nelson
    Amini, Saeed
    Ancuceanu, Robert
    Andrei, Tudorel
    Andrei, Catalina Liliana
    Anjana, Ranjit Mohan
    Ansar, Adnan
    Antonazzo, Ippazio Cosimo
    Antony, Benny
    Anyasodor, Anayochukwu Edward
    Arabloo, Jalal
    Arizmendi, Damian
    Armocida, Benedetta
    Artamonov, Anton A.
    Arulappan, Judie
    Aryan, Zahra
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (03) : 177 - 192
  • [9] Public health and international drug policy
    Csete, Joanne
    Kamarulzaman, Adeeba
    Kazatchkine, Michel
    Altice, Frederick
    Balicki, Marek
    Buxton, Julia
    Cepeda, Javier
    Comfort, Megan
    Goosby, Eric
    Goulao, Joao
    Hart, Carl
    Kerr, Thomas
    Lajous, Alejandro Madrazo
    Lewis, Stephen
    Martin, Natasha
    Mejia, Daniel
    Camacho, Adriana
    Mathieson, David
    Obot, Isidore
    Ogunrombi, Adeolu
    Sherman, Susan
    Stone, Jack
    Vallath, Nandini
    Vickerman, Peter
    Zabransky, Tomas
    Beyrer, Chris
    [J]. LANCET, 2016, 387 (10026) : 1427 - 1480
  • [10] Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010
    Degenhardt, Louisa
    Whiteford, Harvey A.
    Ferrari, Alize J.
    Baxter, Amanda J.
    Charlson, Fiona J.
    Hall, Wayne D.
    Freedman, Greg
    Burstein, Roy
    Johns, Nicole
    Engell, Rebecca E.
    Flaxman, Abraham
    Murray, Christopher J. L.
    Vos, Theo
    [J]. LANCET, 2013, 382 (9904) : 1564 - 1574